1. Home
  2. ASMB vs WKEY Comparison

ASMB vs WKEY Comparison

Compare ASMB & WKEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • WKEY
  • Stock Information
  • Founded
  • ASMB 2005
  • WKEY 1999
  • Country
  • ASMB United States
  • WKEY Switzerland
  • Employees
  • ASMB N/A
  • WKEY N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • WKEY EDP Services
  • Sector
  • ASMB Health Care
  • WKEY Technology
  • Exchange
  • ASMB Nasdaq
  • WKEY Nasdaq
  • Market Cap
  • ASMB 76.9M
  • WKEY 78.1M
  • IPO Year
  • ASMB 2010
  • WKEY N/A
  • Fundamental
  • Price
  • ASMB $15.40
  • WKEY $6.05
  • Analyst Decision
  • ASMB Strong Buy
  • WKEY Strong Buy
  • Analyst Count
  • ASMB 3
  • WKEY 1
  • Target Price
  • ASMB $33.00
  • WKEY $4.00
  • AVG Volume (30 Days)
  • ASMB 14.3K
  • WKEY 201.3K
  • Earning Date
  • ASMB 05-08-2025
  • WKEY 06-10-2025
  • Dividend Yield
  • ASMB N/A
  • WKEY N/A
  • EPS Growth
  • ASMB N/A
  • WKEY N/A
  • EPS
  • ASMB N/A
  • WKEY N/A
  • Revenue
  • ASMB $32,154,000.00
  • WKEY $11,875,000.00
  • Revenue This Year
  • ASMB $33.96
  • WKEY $18.18
  • Revenue Next Year
  • ASMB N/A
  • WKEY $112.51
  • P/E Ratio
  • ASMB N/A
  • WKEY N/A
  • Revenue Growth
  • ASMB 148.33
  • WKEY N/A
  • 52 Week Low
  • ASMB $7.75
  • WKEY $1.61
  • 52 Week High
  • ASMB $19.93
  • WKEY $14.00
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 69.79
  • WKEY 55.68
  • Support Level
  • ASMB $13.13
  • WKEY $6.37
  • Resistance Level
  • ASMB $14.35
  • WKEY $7.49
  • Average True Range (ATR)
  • ASMB 0.73
  • WKEY 0.74
  • MACD
  • ASMB 0.10
  • WKEY -0.01
  • Stochastic Oscillator
  • ASMB 84.79
  • WKEY 44.76

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

Share on Social Networks: